Successful treatment of peripartum cardiomyopathy with plasmapheresis

Acta Cardiologica Sinica

Volumn 29, Issue 5, 2013, Pages 471-474

  Wang, Tzu Lin ^a   Hung, Huei Fong ^a   Shyu, Kou Gi ^a   Yeh, Jiann Horng ^a   Chiu, Hou Chang ^a  

^a SHIN KONG WU HO SU MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Peripartum cardiomyopathy; Plasmapheresis

Indexed keywords

SPIRONOLACTONE;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CASE REPORT; CESAREAN SECTION; CLINICAL PROTOCOL; DELIVERY; DYSPNEA; EMERGENCY; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEMODIALYSIS; HUMAN; INTRAAORTIC BALLOON PUMP; LOWER LEG; MULTIPLE ORGAN FAILURE; OUTCOME ASSESSMENT; PERIPARTUM CARDIOMYOPATHY; PLASMAPHERESIS; PREECLAMPSIA; TREATMENT DURATION;

EID: 84886885818     PISSN: 10116842     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Abboud J, Murad Y, Chen-Scarabelli C, et al. Peripartum cardiomyopathy: a comprehensive review. Int J Cardiol 2007;118: 295-303.
2. Johnson-Coyle L, Jensen L, Sobey A; American College of Cardiology Foundation; American Heart Association. Peripartum cardiomyopathy: review and practice guidelines. Am J Crit Care 2012;21:89-98.
3. Sliwa K, Hilfiker-Kleiner D, Petrie MC, et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy. Eur J Heart Fail 2010;12:767-78.
4. Pearson GD, Veille JC, Rahimtoola S, et al. Peripartum cardiomyopathy: National Heart, Lung, and Blood Institute and Office of Rare Diseases (National Institutes of Health) workshop recommendations and review. JAMA 2000;283:1183-8.
5. Lampert MB, Lang RM. Peripartum cardiomyopathy. Am Heart J 1995;130:860.
6. Bozkurt B, Villaneuva FS, Holubkov R, et al. Intravenous immune globulin in the therapy of peripartum cardiomyopathy. J Am Coll Cardiol 1999;34:177-80.
7. Szczepiorkowski ZM,Winters JL, Bandarenko N, et al. Guidelines on the use of therapeutic apheresis in clinical practice-evidence- based approach from the Apheresis Applications Committee of the American Society for Apheresis. J Clin Apher 2010;25:83-177.
8. Winters JL. Apheresis in the treatment of idiopathic dilated cardiomyopathy. J Clin Apher 2012;27:312-9.
9. Houck PD, StrimelWJ, Gantt DS, et al. Should we establish a new protocol for the treatment of peripartum myocardial infarction? Tex Heart Inst J 2012;39:244-8.